Abstract:We present major results from a tremendously broad screen of drug‐naïve behavioral traits in mice from the knockout Mouse Project, resulting in the identification of multiple null alleles predicted to cause abnormal drug and alcohol intake. We validated these predictions using oral drug self‐administration. In this study, we show that abnormal drug and alcohol intake phenotypes have nonlinear but significant complex associations with underlying behavioral traits such that extreme effects on various traits can lead to similar outcomes on the same drug intake trait and different outcomes on others. Substance use disorders are heritable disorders characterized by compulsive drug use, the biological mechanisms for which remain largely unknown. Genetic correlations reveal that predisposing drug‐naïve phenotypes, including anxiety, depression, novelty preference and sensation seeking, are predictive of drug‐use phenotypes, thereby implicating shared genetic mechanisms. High‐throughput behavioral screening in knockout (KO) mice allows efficient discovery of the function of genes. We used this strategy in two rounds of candidate prioritization in which we identified 33 drug‐use candidate genes based upon predisposing drug‐naïve phenotypes and ultimately validated the perturbation of 22 genes as causal drivers of substance intake. We selected 19/221 KO strains (8.5%) that had a difference from control on at least one drug‐naïve predictive behavioral phenotype and determined that 15/19 (~80%) affected the consumption or preference for alcohol, methamphetamine or both. No mutant exhibited a difference in nicotine consumption or preference which was possibly confounded with saccharin. In the second round of prioritization, we employed a multivariate approach to identify outliers and performed validation using methamphetamine two‐bottle choice and ethanol drinking‐in‐the‐dark protocols. We identified 15/401 KO strains (3.7%, which included one gene from the first cohort) that differed most from controls for the predisposing phenotypes. 8 of 15 gene deletions (53%) affected intake or preference for alcohol, methamphetamine or both. Using multivariate and bioinformatic analyses, we observed multiple relations between predisposing behaviors and drug intake, revealing many distinct biobehavioral processes underlying these relationships. The set of mouse models identified in this study can be used to characterize these addiction‐related processes further.

A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity

Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Hereditary and cortical morphological biomarker of sensitivity to reward in short-term withdrawal methamphetamine abusers

Variants in GABBR1 Gene Are Associated with Methamphetamine Dependence and Two Years’ Relapse after Drug Rehabilitation

Expression Quantitative Trait Loci and Genetic Regulatory Network Analysis Reveals Thatgabra2is Involved in Stress Responses in the Mouse

The Vulnerability to Methamphetamine Dependence and Genetics: A Case-Control Study Focusing on Genetic Polymorphisms at Chromosomal Region 5Q31.3

Systems genetics of intravenous cocaine self-administration in the BXD recombinant inbred mouse panel

Atp1a2 and Kcnj9 are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains

GABRB1 Single Nucleotide Polymorphism Associated with Altered Brain Responses (but Not Performance) During Measures of Impulsivity and Reward Sensitivity in Human Adolescents.

Identification of Novel Risk Loci with Shared Effects on Alcoholism, Heroin, and Methamphetamine Dependence

Identification of PROK2 Gene Polymorphisms As Predictors of Methamphetamine Use Disorder Risk and Indicators of Craving Scale in the Chinese Han Population.

Discovery and validation of genes driving drug‐intake and related behavioral traits in mice

Restoring GABAB receptor expression in the ventral tegmental area of methamphetamine addicted mice inhibits locomotor sensitization and drug seeking behavior

Effects of positive mGlu5 modulation on D2 signaling and nicotine-conditioned place preference: Mechanisms of epigenetic inheritance in a transgenerational model of drug abuse vulnerability in psychosis

and are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains

Genomic Loci Influencing Cue-Reactivity in Heterogeneous Stock Rats

Genome-wide Association Study Identifies Common Genetic Risk Factors for Alcohol, Heroin and Methamphetamine Dependence

Evaluation of Adenosine A2A Receptor Gene Polymorphisms As Risk Factors of Methamphetamine Use Disorder Susceptibility and Predictors of Craving Degree

Post-GWAS Analysis of Six Substance Use Traits Improves the Identification and Functional Interpretation of Genetic Risk Loci.

Splice-Site Variants in the Gene Encoding GABA-A Receptor Delta Subunit Are Associated with Amphetamine Use in Patients under Methadone Maintenance Treatment